entertainment -WSS

entertainment

author：comprehensive 2025-10-01 01:00:13 - browse：39

Stock illustration of computer and medication — Adobe

Digital therapeutics company Click Therapeutics announced Wednesday it will acquire the assets of Better Therapeutics, developer of a software-based treatment for diabetes. Click, which did not disclose how much it is paying for the assets, hopes to adapt Better’s tech for use alongside GLP-1 medications.

Better Therapeutics announced in March that it was delisting from the Nasdaq stock exchange and shutting down operations as it sought strategic alternatives. The company had been, since last year, searching for ways to stay afloat as its cash reserves dwindled.

Last, year, Better received Food and Drug Administration clearance for AspyreRx, a prescription app that delivers cognitive behavioral therapy and had been shown to reduce A1c levels in people with type 2 diabetes. Still, the company has been unable to ramp up significant commercial traction. Better also had a pipeline of other products targeting cardiometabolic conditions, and had made early claims about the benefits of AspyreRx in people taking GLP-1s for diabetes management.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — and get additional analysis of the technologies disrupting health care — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Walensky prepares to leave CDC — and Congress — behind
Next article： Pumping milk in bathrooms at health conferences is common

hotspot

focus

WSS

TikTok, Instagram influencers need more rules for drug ads

FDA approval of Sarepta Duchenne genetic therapy gives me hope

After affirmative action ruling, medical educators look to 'holistic review'

Peter Hotez and the public health issue of online harassment

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

Microsoft launches AI tool for clinical documentation through Epic

leisure time

entertainment

This article is exclusive to STAT+ subscribers

Unlock this article — and get additional analysis of the technologies disrupting health care — by subscribing to STAT+.

hotspot

What does generative AI mean for health care? We asked experts

Cardiologists urge adding sexual orientation, gender identity to health records

Medical records are filled with copy

Peter Hotez and the public health issue of online harassment

FDA approval of Sarepta Duchenne genetic therapy gives me hope

State Dept. review finds Biden bears some blame for Afghanistan failures

State Dept. review finds Biden bears some blame for Afghanistan failures

Flu vaccine reformulation won't be easy, manufacturers warn

Jerome Adams on the need for new antivirals for Covid

Sanofi to acquire U.S. biotech Inhibrx in $2.2 billion deal

entertainment

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

Maisha Meds is a PBM, but don't call it that

Jerome Adams on the need for new antivirals for Covid

Activists slam private health insurers over coverage restrictions

The high cost of giving birth even with insurance

Dana Farber says 6 studies to be retracted and 31 corrected

Wikipedia

hotspot

focus

explore